AKTX Akari Therapeutics Plc - American Depositary Shares
$7,75
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 13, 2026
52 Haftlık Aralık
$0–$29
26% of range
Analist Derecelendirmesi
BUY
10 analysts
Fiyat Hedefi
$28
+266% upside
P/E (TTM)
—
ROE
-64.1%
Net Kâr Marjı
—
AKTX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$7.75
Piyasa Değeri
$701.66B
P/E (TTM)
—
EPS (TTM)
$0.00
Gelir (TTM)
—
Temettü Verimi
—
ROE
-64.1%
D/E Borç/Özsermaye
0.0
52 Haftlık Aralık
$0 – $29
AKTX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$0.00
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2014-12-31
→
2015-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
AKTX
Akran Ortalaması
P/B (F/D)
24769.2
0.9
EV / EBITDA
-40617.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
AKTX
Akran Ortalaması
ROA
-35.1%
-74.6%
ROE
-64.1%
-92.1%
ROIC
-57.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
AKTX
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.0
0.0
Current Ratio (Cari Oran)
0.4
2.7
Quick Ratio (Cari Oran)
0.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
AKTX
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
AKTX
Akran Ortalaması
AKTX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
10 analist
- Güçlü Al 3 30,0%
- Al 6 60,0%
- Tut 1 10,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
2 analist · 2026-08-15
Medyan
$28.39
← Tüm hedeflerin altında
$7.75
Düşük
$26.78
Yüksek
$30.00
Medyan hedef
$28.39
+266,3%
Ortalama hedef
$28.39
+266,3%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
1.1%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-1.57 | $-1.40 | -0.17% |
| 31 Aralık 2025 | $0.00 | $-1.53 | 1.5% |
| 30 Eylül 2025 | $0.00 | $-3.13 | 3.1% |
| 30 Haziran 2025 | $0.00 | $-4.69 | 4.7% |
| 31 Mart 2021 | $0.00 | $0.00 | 0.00% |
| 31 Mart 2020 | $-2.60 | $0.00 | -2.6% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| AKTX | $26.17B | — | — | — | -64.1% | — |
| SNGX | $14M | -0.6 | -85.8% | — | -311.2% | — |
| CELZ | — | -0.8 | -45.5% | — | — | — |
| AQB | $4M | -0.2 | -21.2% | — | -315.5% | — |
| FBLG | — | -0.5 | — | — | — | — |
| ALZN | $5M | -0.4 | — | — | -598.1% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $7M | $5M | $10M | $6M | $2M | $1M | |
| SG&A Expense | $9M | $10M | $11M | $14M | $6M | $303.1K | $2M | |
| Operating Expenses | $17M | $22M | $17M | · | $31M | $2M | · | |
| Operating Income | $-17M | $-22M | $-17M | $-23M | $-31M | $-2M | $-4M | |
| Interest Expense | $100.0K | · | · | · | $3M | $5.4K | · | |
| Interest Income | $1.0K | $8.0K | $82.0K | $46.0K | $20.7K | $91 | · | |
| Other Non-op | $-1M | $2M | $-19.0K | $-142.0K | $-15M | $-28.3K | $-14.0K | |
| Pretax Income | $-18M | $-20M | $-10M | $-17.7K | $-45M | $-2M | · | |
| Income Tax | $-1M | · | $0 | · | $0 | $0 | · | |
| Net Income | $-17M | $-20M | $-10M | $-18M | $-45M | $-2M | $-4M | |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| Shares (Basic) | 67,328,128,638 | 23,888,010,485 | 9,788,980,193 | 6,243,462,410 | 852,088,530 | 85,515,588 | 21,075,065 | |
| Shares (Diluted) | 67,328,128,638 | 23,888,010,485 | 9,788,980,193 | 6,243,462,410 | 852,088,530 | 85,515,588 | 21,075,065 | |
| EBITDA | $-17M | $-22M | $-17M | · | $-31M | $-10M | · |
Bilanço 24
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $0 | $4M | $13M | $69M | $3M | $553.7K | |
| Prepaid Expense | $185.0K | $92.0K | $299.0K | $465.0K | $728.1K | $7.8K | · | |
| Other Current Assets | $14.0K | $201.0K | $197.0K | $100.0K | · | · | · | |
| Current Assets | $5M | $3M | $4M | $14M | $70M | $3M | $8M | |
| PP&E (Net) | · | · | · | · | $40.5K | $0 | $0 | |
| PP&E (Gross) | · | · | · | · | · | $67.0K | $10.0K | |
| Goodwill | $8M | $8M | · | · | · | · | · | |
| Intangibles | · | · | $14.0K | $17.0K | $52.5K | $59.4K | · | |
| Total Assets | $48M | $51M | $4M | $14M | $70M | $3M | $8M | |
| Accounts Payable | $9M | $12M | $2M | $947.0K | $4M | $555.5K | · | |
| Accrued Liabilities | $2M | $3M | $2M | $3M | $408.2K | $43.0K | $403.0K | |
| Short-term Debt | $81.0K | $659.0K | · | · | · | · | · | |
| Current Liabilities | $12M | $20M | $5M | · | $21M | $1M | $1M | |
| Deferred Tax | $7M | $8M | · | · | · | · | · | |
| Other Non-current Liabilities | $31.0K | $383.0K | · | · | · | $33.0K | $0 | |
| Total Liabilities | $20M | $28M | $5M | $12M | $21M | $1M | · | |
| Total Debt | $81.0K | $659.0K | · | · | · | · | · | |
| Common Stock | · | $5M | $1M | $745.0K | $18M | $11M | $675.0K | |
| Paid-in Capital | $234M | $213M | · | · | · | · | · | |
| Retained Earnings | $-265M | $-247M | $-227M | $-217M | $-57M | $-11M | $-21M | |
| AOCI | $-782.0K | $-738.0K | $-1M | $-771.0K | $156.5K | $46.1K | $-33.4K | |
| Stockholders' Equity | $28M | $22M | $-229.0K | $2M | $49M | $2M | $400.7K | |
| Liabilities + Equity | $48M | $51M | $4M | $14M | $70M | $3M | $8M | |
| Shares Outstanding | 90,536,879,533 | 53,186,919,523 | 13,234,315,298 | 7,444,917,123 | 1,177,693,383 | 722,345,600 | 40,227,953 |
Nakit Akışı 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | $14.0K | $4.0K | $4.0K | · | · | · | |
| Stock-based Comp | $3M | $2M | $1M | $735.0K | $1M | $0 | $94.0K | |
| Deferred Tax | $-1M | · | · | · | · | · | · | |
| Restructuring | $-50.0K | $2M | · | · | · | · | · | |
| Other Non-cash | · | $5M | $-8M | · | · | · | · | |
| Operating Cash Flow | $-11M | $-13M | $-16M | $-22M | $-5M | $-1M | $-5M | |
| CapEx | · | · | · | · | $10.6K | $0 | $0 | |
| Investing Cash Flow | · | $382.0K | · | · | $1M | $0 | $0 | |
| Stock Issued | $11M | $12M | $7M | $25M | $75M | $4M | $0 | |
| Net Stock Activity | $11M | $12M | $7M | · | $75M | $0 | · | |
| Financing Cash Flow | $13M | $11M | $7M | $25M | $69M | $4M | $12M | |
| Net Change in Cash | $3M | $-1M | $-9M | $4M | $66M | $3M | $7M | |
| Free Cash Flow | · | · | · | · | $-5M | $-10M | · | |
| Levered FCF | · | · | · | · | $-8M | · | · |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| ROA | -35.1% | -72.1% | -110.1% | · | -123.7% | -134.8% | · | |
| ROE | -64.1% | -254.8% | 125100.0% | · | -177.9% | -126.4% | · | |
| ROIC | -57.5% | -94.6% | 7338.9% | · | -62.8% | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.1 | · | · | 3.3 | 4.7 | · | |
| Quick Ratio | 0.0 | 0.1 | · | · | 3.3 | 4.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | -172.8 | · | · | · | -10.0 | · | · |
Değerleme (TTM) 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-17M | $-20M | $-10M | · | $-45M | $-2M | · | |
| Market Cap | $26.17B | $64.89B | $41.29B | · | $341.53B | $53.41B | · | |
| Enterprise Value | $26.17B | $64.89B | · | · | · | · | · | |
| P/B | 923.6 | 2919.1 | -180310.3 | · | 7010.1 | 11005.7 | · | |
| P / Tangible Book | 1315.0 | 4702.4 | · | · | · | · | · | |
| P / Cash Flow | -2475.9 | -5169.5 | -2512.8 | · | -68779.7 | -5645.4 | · | |
| P / FCF | · | · | · | · | -68633.7 | -5611.6 | · | |
| EV / EBITDA | -1514.6 | -3000.0 | · | · | · | · | · | |
| Earnings Yield | 0.00% | 0.00% | 0.00% | · | · | · | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $1M | $1M | $249.0K | $667.0K | $813.0K | $1M | $143.0K | $3M | $2M | $3M | $1M | $3M | $1M | $142.0K | $2M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $3M | $2M | $1M | $3M | $1M | $99.7K | |
| Operating Expenses | · | $16M | · | · | · | $4M | · | · | · | $6M | · | $4M | $4M | $23M | · | $2M | |
| Operating Income | $-5M | $-16M | $-3M | $-7M | $-3M | $-4M | $-5M | $-3M | $-7M | $-6M | $-5M | $-4M | $-4M | $-23M | $-1M | $-2M | |
| Interest Expense | · | · | $0 | $100.0K | · | · | · | · | $51.0K | · | · | $0 | $-6.0K | $3M | · | $4.6K | |
| Interest Income | · | · | $0 | $1.0K | · | · | $1.0K | $3.0K | $2.0K | $2.0K | $7.0K | $30.8K | $19.3K | $1.4K | · | $0 | |
| Other Non-op | $-205.0K | $444.0K | $-2M | $-84.0K | $1M | $-180.0K | $2M | $32.0K | $-109.0K | $-2.0K | $27.0K | $866.6K | $11M | $-25M | $-215.0K | $-42.2K | |
| Pretax Income | $-5M | $-15M | $-5M | $-7M | $-2M | $-4M | $-4M | $-3M | · | · | · | $-3M | $7M | $-49M | $-2M | $-2M | |
| Income Tax | · | $-859.0K | $85.0K | $-1M | · | · | · | · | · | $0 | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $-14M | $-5M | $-6M | $-2M | $-4M | $-4M | $-3M | $-8M | $-6M | $-4M | $-3M | $7M | $-49M | $-2M | $-2M | |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | |
| Shares (Basic) | 143,317,469,445 | 118,757,013,401 | -115,530,287,566 | 65,326,236,698 | 62,943,895,665 | 54,588,283,841 | -32,787,621,994 | 24,386,005,523 | 18,836,478,977 | 13,453,147,979 | -17,917,475,885 | 1,177,693,383 | 109,727,643 | 781,738,789 | · | 722,345,600 | |
| Shares (Diluted) | 143,317,469,445 | 118,757,013,401 | -115,530,287,566 | 65,326,236,698 | 62,943,895,665 | 54,588,283,841 | -32,787,621,994 | 24,386,005,523 | 18,836,478,977 | 13,453,147,979 | -18,016,471,589 | 1,177,693,383 | 109,727,643 | 781,738,789 | · | 722,345,600 | |
| EBITDA | $-5M | $-16M | · | $-7M | $-3M | $-4M | · | $-3M | $-7M | $-6M | · | $-4M | · | $-23M | $-1M | $-2M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | $0 | $2M | $3M | $3M | $0 | $2M | $4M | $1M | $4M | $61M | $69M | $79M | $3M | $4M | |
| Prepaid Expense | $532.0K | $731.0K | $185.0K | $349.0K | $447.0K | $627.0K | $92.0K | $396.0K | $805.0K | $1M | $299.0K | $1M | $728.1K | · | · | · | |
| Other Current Assets | $38.0K | $30.0K | $14.0K | $53.0K | $83.0K | $80.0K | $201.0K | $92.0K | $94.0K | $232.0K | $197.0K | · | · | · | · | · | |
| Current Assets | $8M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $4M | $63M | $70M | $79M | $3M | $4M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $74.8K | $40.5K | $34.9K | $40.0K | $44.0K | |
| Goodwill | · | · | $8M | $8M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $14.0K | $49.0K | $52.5K | $58.1K | · | · | |
| Total Assets | $39M | $34M | $48M | $45M | $51M | $51M | $51M | $3M | $5M | $3M | $4M | $63M | $70M | $79M | $3M | $4M | |
| Accounts Payable | $9M | $9M | $9M | $11M | $12M | $13M | $12M | $5M | $5M | $3M | $2M | $625.4K | $4M | $4M | · | · | |
| Accrued Liabilities | $4M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $231.9K | $408.2K | $4M | · | · | |
| Short-term Debt | · | $49.0K | $81.0K | $198.0K | $179.0K | $228.0K | $659.0K | $200.0K | $600.0K | $900.0K | · | · | · | · | · | · | |
| Current Liabilities | $14M | $13M | $12M | $16M | $17M | $21M | $20M | $9M | $9M | $6M | $5M | $17M | $21M | $38M | $960.0K | $910.0K | |
| Deferred Tax | $6M | $6M | $7M | $7M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $31.0K | $69.0K | $128.0K | $266.0K | $383.0K | · | · | · | · | · | · | · | $43.0K | $38.0K | |
| Total Liabilities | $20M | $20M | $20M | $23M | $25M | $29M | $28M | · | · | · | $5M | $17M | $21M | $38M | · | · | |
| Total Debt | · | $49.0K | · | $198.0K | $179.0K | $228.0K | · | $200.0K | $600.0K | $900.0K | · | · | · | · | · | · | |
| Common Stock | $1.0K | · | · | $7M | $7M | $6M | $5M | $2M | $2M | $2M | $1M | $18M | $18M | $18M | $927.0K | $927.0K | |
| Paid-in Capital | $244M | $235M | $234M | $224M | $221M | · | $213M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-284M | $-279M | $-265M | $-259M | $-253M | $-251M | $-247M | $-243M | $-241M | $-233M | $-227M | $-60M | $-57M | $-63M | $-34M | $-33M | |
| AOCI | $-695.0K | $-768.0K | $-782.0K | $-1M | $-1M | $-773.0K | $-738.0K | $-926.0K | $-749.0K | $-761.0K | $-1M | $-36.5K | $156.5K | $197.1K | · | · | |
| Stockholders' Equity | $19M | $14M | $28M | $23M | $26M | $22M | $22M | $-7M | $-4M | $-4M | $-229.0K | $46M | $49M | $41M | $973.0K | $3M | |
| Liabilities + Equity | $39M | $34M | $48M | $45M | $51M | $51M | $51M | $3M | $5M | $3M | $4M | $63M | $70M | $79M | $3M | $4M | |
| Shares Outstanding | 140,032,769,533 | 91,567,009,533 | 90,536,879,533 | 65,229,461,523 | 65,229,461,523 | 57,752,981,523 | 53,186,919,523 | 24,289,231,523 | 24,289,232,698 | 15,973,121,298 | 13,234,315,298 | 1,177,693,383 | 1,177,693,383 | 1,177,693,383 | 55,636,283 | 55,636,283 |
Nakit Akışı 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $1.0K | $0 | $0 | $13.0K | $1.0K | · | · | · | · | · | |
| Stock-based Comp | $711.0K | $305.0K | $471.0K | $685.0K | $719.0K | $1M | $1M | $248.0K | $445.0K | $296.0K | $304.0K | $816.8K | $963.8K | $-31.9K | $49.0K | $0 | |
| Deferred Tax | $0 | $-859.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | $-100.0K | $0 | $100.0K | $-50.0K | $3M | $-3M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $-2M | $-1M | $-5M | $-4M | $-4M | $-7M | $-7M | $5M | $-1M | $-2M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $42.1K | · | · | · | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $-42.1K | $-18.8K | $1M | $0 | $0 | |
| Stock Issued | · | · | $5M | $0 | $4M | $1M | $3M | $-133.0K | $7M | $2M | $4M | · | $0 | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $2M | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $53.0K | $6M | $2M | $3M | $2M | $2M | $-443.0K | $8M | $2M | $4M | · | $-3M | $72M | $0 | $0 | |
| Net Change in Cash | $5M | $-2M | $3M | $-227.0K | $129.0K | $-17.0K | $413.0K | $-2M | $3M | $-3M | $-886.0K | $-7M | $-10M | $79M | $-1M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | · |
Kârlılık 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.7% | -34.1% | · | -26.6% | -6.8% | -13.8% | · | -7.1% | -188.1% | -16.9% | · | -8.9% | · | -123.1% | -112.9% | -107.3% | |
| ROE | -21.8% | -80.0% | · | -80.0% | -17.3% | -40.7% | · | -16.7% | 553.7% | -26.0% | · | -12.2% | · | -235.8% | -343.5% | -178.6% | |
| ROIC | · | -103.1% | · | -27.7% | · | · | · | · | · | · | · | -8.3% | · | -56.4% | -149.6% | -72.7% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.6 | 0.4 | · | 3.8 | · | 2.1 | 3.0 | 4.7 | |
| Quick Ratio | 0.6 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.5 | 0.2 | · | 3.7 | · | 2.1 | 2.8 | 4.4 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | -0.0 | -0.2 | -0.3 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -74.0 | · | · | · | · | -146.1 | · | · | · | · | -7.6 | · | · |
Değerleme (TTM) 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | $-26M | · | $-15M | $-16M | $-20M | · | $-19M | $-20M | $-11M | · | $-55M | · | $-52M | $-6M | $-6M | |
| Market Cap | $1.43T | $471.57B | · | $65.88B | $76.32B | $71.61B | · | $71.65B | $65.58B | $29.79B | · | $329.75B | · | $565.18B | $6.45B | $8.46B | |
| Enterprise Value | · | $471.57B | · | $65.88B | $76.32B | $71.61B | · | $71.65B | $65.58B | $29.79B | · | · | · | · | · | · | |
| P/B | 77151.7 | 32793.5 | · | 2903.9 | 2980.6 | 3293.2 | · | -10704.1 | -17710.2 | -8384.4 | · | 7113.2 | · | 13674.2 | 6632.9 | 3258.8 | |
| P / Tangible Book | 77151.7 | 32793.5 | · | 4621.0 | 4443.6 | 5378.0 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -189537.8 | · | · | · | -33308.7 | · | · | · | -7366.4 | · | -44318.4 | · | · | · | -3844.0 | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | -44069.1 | · | · | · | · | |
| EV / EBITDA | · | -29925.6 | · | -8897.8 | -24468.1 | -20315.3 | · | -24479.4 | -8803.5 | -4984.8 | · | · | · | · | · | · | |
| Earnings Yield | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-17M | $-20M | $-10M | $-18M | $-45M |
| Seyreltilmiş Hisse Başı Kâr | $0.00 | $0.00 | $0.00 | $0.00 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.0 | 0.0 | — | — | — |
| Cari Oran | 0.4 | 0.1 | — | — | 3.3 |
| Cari Oran | 0.0 | 0.1 | — | — | 3.3 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | — | — | — | $-5M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 1 dosya · $6K toplam · Tarih itibarıyla 31 Aralık 2025
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Skyview Financial Group LLC | $5.946 | 20.575 | 100,00% | Hisse senetleri |
Şirket yöneticileri 24 içeriden öğrenenler · 8 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Abizer Gaslightwala | CEO | 24 Haziran 2026 A | 277.574 | 0 | 0 | $0 |
| Rachelle Suzanne Jacques | Chief Executive Officer | 26 Nisan 2024 A | 1.018.027.792 | 0 | 0 | $0 |
| Gur Roshwalb | Chief Executive Officer | 21 Eylül 2015 A | — | 0 | 0 | $0 |
| Torsten Hombeck | CFO | 20 Mart 2025 A | 200 | 0 | 0 | $0 |
| Wendy F Dicicco | Interim CFO | 01 Mayıs 2024 A | 158.473.915 | 0 | 0 | $0 |
| Dov Elefant | Chief Financial Officer | 21 Eylül 2015 A | — | 0 | 0 | $0 |
| Clive Richardson | COO | 21 Eylül 2015 A | — | 0 | 0 | $0 |
| Robert M Shaw | General Counsel and Secretary | 23 Mart 2016 A | — | 0 | 0 | $0 |
| Samir R. Patel | Yönetim kurulu üyesi | 07 Temmuz 2026 M | 98.241 | 0 | 0 | $0 |
| Ray Prudo, M.D. | Yönetim kurulu üyesi | 20 Mart 2025 A | 2.484.990 | 0 | 0 | $0 |
| James R Neal | Yönetim kurulu üyesi | 20 Mart 2025 A | 36.271 | 0 | 0 | $0 |
| Hoyoung Huh | Yönetim kurulu üyesi | 20 Mart 2025 A | 4.695.854 | 0 | 0 | $0 |
| Sandip I Patel | Yönetim kurulu üyesi | 06 Mart 2025 A | 496.499 | 0 | 0 | $0 |
| Mohamed Wa'El Ahmed Hashad | Yönetim kurulu üyesi | 28 Haziran 2024 A | — | 0 | 0 | $0 |
| Michael Grissinger | Yönetim kurulu üyesi | 28 Haziran 2024 A | — | 0 | 0 | $0 |
| Donald A Williams | Yönetim kurulu üyesi | 28 Haziran 2024 A | — | 0 | 0 | $0 |
| David Byrne | Yönetim kurulu üyesi | 29 Haziran 2016 A | — | 0 | 0 | $0 |
| Stuart Ungar | Yönetim kurulu üyesi | 29 Haziran 2016 A | — | 0 | 0 | $0 |
| James Hill | Yönetim kurulu üyesi | 29 Haziran 2016 A | — | 0 | 0 | $0 |
| Mark S Cohen | Yönetim kurulu üyesi | 29 Haziran 2016 A | 1.055.600 | 0 | 0 | $0 |
| Donald Allen Williams | Yönetim kurulu üyesi | 29 Haziran 2016 A | — | 0 | 0 | $0 |
| Allan Shaw | Yönetim kurulu üyesi | 25 Kasım 2015 A | — | 0 | 0 | $0 |
| Kameel D. Farag | — | 16 Temmuz 2026 A | 21.581 | 0 | 0 | $0 |
| Robert B Bazemore | — | 20 Mart 2025 A | 44.642 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Ray Prudo, M.D., RPC Pharma Limited, Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company ×7 başvurular | 04 Mart 2026 | 0,87% | Değişiklik | — | SEC |
| Samir R. Patel | 04 Mart 2026 | 10,40% | Değişiklik | — | SEC |
| Samir R. Patel (2) ×2 başvurular | 06 Aralık 2024 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 18 Haziran 2024 | — | İlk başvuru | — | SEC |
| Praxis Trustees Limited As trustee of The Sonic Healthcare Holding Company, RPC Pharma Limited, Ray Prudo, M.D. | 18 Ekim 2021 | — | İlk başvuru | — | SEC |
| RPC Pharma Limited, Ray Prudo, M.D. ×3 başvurular | 30 Mart 2020 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.